HEPAGLAN 25 INJECTION

Common side effects of HEPAGLAN 25 INJECTION may include bruising, hematomas, pain at the injection site, and elevated liver enzymes. Serious side effects can include bleeding, Heparin-induced thrombocytopenia (HIT), hypersensitivity reactions, and osteoporosis.

HEPAGLAN 25 INJECTION is generally considered safe during pregnancy and breastfeeding. It does not cross the placenta significantly and is not expected to harm the baby when used appropriately. However, its use should be under the guidance of a healthcare provider.

HEPAGLAN 25 INJECTION dosing varies based on the patient's weight, medical condition, and desired anticoagulant effect. The dosage is usually adjusted based on regular monitoring of blood clotting parameters, such as activated partial thromboplastin time (aPTT) or anti-Xa assay.

Yes, HEPAGLAN 25 INJECTION increases the risk of bleeding. Patients should be closely monitored for signs of bleeding and inform their healthcare provider promptly if they experience any unusual bleeding or bruising.

HEPAGLAN 25 INJECTION can be used in children and the elderly. However, special consideration is required in these populations due to differences in dosing and potential age-related factors that may affect its use.

Please consult your doctor or pharmacist for information on how HEPAGLAN 25 INJECTION interacts with other medications.

Patients should inform their healthcare providers about their medical history, including any bleeding disorders, liver or kidney problems, recent surgeries, and allergies, to determine the appropriate dosage and administration method. Regular monitoring of blood clotting parameters, such as activated partial thromboplastin time (aPTT) or anti-Xa assay, is crucial to maintain the desired anticoagulant effect and prevent bleeding or thrombosis. Patients should follow the prescribed dosage and administration instructions precisely and report any unusual bleeding, bruising, or allergic reactions promptly. It is advisable to avoid activities or medications that may increase the risk of bleeding while on Hepaglan 25000IU Injection. By adhering to these instructions and maintaining open communication with healthcare providers, patients can minimize risks and maximize the benefits of this therapy.

HEPARIN is the molecule/combination used for making HEPAGLAN 25 INJECTION.

HEPAGLAN 25 INJECTION is prescribed for Cardiology related ailments/diseases/conditions.